Correlation Between ZyVersa Therapeutics and Alzamend Neuro

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Alzamend Neuro, you can compare the effects of market volatilities on ZyVersa Therapeutics and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Alzamend Neuro.

Diversification Opportunities for ZyVersa Therapeutics and Alzamend Neuro

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between ZyVersa and Alzamend is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Alzamend Neuro go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Alzamend Neuro

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 1.04 times more return on investment than Alzamend Neuro. However, ZyVersa Therapeutics is 1.04 times more volatile than Alzamend Neuro. It trades about -0.36 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.4 per unit of risk. If you would invest  141.00  in ZyVersa Therapeutics on November 27, 2024 and sell it today you would lose (29.00) from holding ZyVersa Therapeutics or give up 20.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ZyVersa Therapeutics  vs.  Alzamend Neuro

 Performance 
       Timeline  
ZyVersa Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ZyVersa Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ZyVersa Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Alzamend Neuro 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Alzamend Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

ZyVersa Therapeutics and Alzamend Neuro Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZyVersa Therapeutics and Alzamend Neuro

The main advantage of trading using opposite ZyVersa Therapeutics and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.
The idea behind ZyVersa Therapeutics and Alzamend Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device